Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

An open-label trial of risperidone augmentation for refractory anxiety disorders.

Simon NM, Hoge EA, Fischmann D, Worthington JJ, Christian KM, Kinrys G, Pollack MH.

J Clin Psychiatry. 2006 Mar;67(3):381-5.

PMID:
16649823
2.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
3.

Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.

Gao K, Muzina D, Gajwani P, Calabrese JR.

J Clin Psychiatry. 2006 Sep;67(9):1327-40. Review.

PMID:
17017818
4.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
5.

Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders.

Keck PE Jr, Strawn JR, McElroy SL.

J Clin Psychiatry. 2006;67 Suppl 1:8-15. Review.

6.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
7.

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.

Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF.

Mol Psychiatry. 2006 Jul;11(7):622-32. Epub 2006 Apr 4. Review. Erratum in: Mol Psychiatry. 2006 Aug;11(8):795.

PMID:
16585942
8.

Efficacy and safety of treatments for refractory generalized anxiety disorder: a systematic review.

Samuel M, Zimovetz EA, Gabriel Z, Beard SM.

Int Clin Psychopharmacol. 2011 Mar;26(2):63-8. doi: 10.1097/YIC.0b013e328341bb4a. Review.

PMID:
21088608
9.

Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.

Lorenz RA, Jackson CW, Saitz M.

Pharmacotherapy. 2010 Sep;30(9):942-51. doi: 10.1592/phco.30.9.942. Review.

PMID:
20795849
10.

Anxiety disorders in schizophrenia.

Braga RJ, Petrides G, Figueira I.

Compr Psychiatry. 2004 Nov-Dec;45(6):460-8. Review.

PMID:
15526257
11.

Use of atypical antipsychotics in refractory depression and anxiety.

Nemeroff CB.

J Clin Psychiatry. 2005;66 Suppl 8:13-21. Review.

12.

[Treatment-resistant anxiety disorders: social phobia, generalized anxiety disorder and panic disorder].

Menezes GB, Fontenelle LF, Mululo S, Versiani M.

Rev Bras Psiquiatr. 2007 Oct;29 Suppl 2:S55-60. Review. Portuguese.

13.

The pharmacologic treatment of anxiety disorders: a review of progress.

Ravindran LN, Stein MB.

J Clin Psychiatry. 2010 Jul;71(7):839-54. doi: 10.4088/JCP.10r06218blu. Review.

PMID:
20667290
14.

Anxiety associated with comorbid depression.

Möller HJ.

J Clin Psychiatry. 2002;63 Suppl 14:22-6. Review.

15.

Buspirone in the long-term treatment of generalized anxiety disorder.

Feighner JP.

J Clin Psychiatry. 1987 Dec;48 Suppl:3-6. Review.

PMID:
3320034
16.

Sequential treatment of mood and anxiety disorders.

Fava GA, Ruini C, Rafanelli C.

J Clin Psychiatry. 2005 Nov;66(11):1392-400. Review.

PMID:
16420076
17.

Pharmacotherapy of generalized anxiety disorder.

Davidson JR.

J Clin Psychiatry. 2001;62 Suppl 11:46-50; discussion 51-2. Review.

18.

Functional classification of anxiety-panic.

Liebowitz MR.

Int Clin Psychopharmacol. 1993 Sep;8 Suppl 1:47-52. Review. No abstract available.

PMID:
7902853
19.

Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission.

Pollack MH.

J Clin Psychiatry. 2001;62 Suppl 19:20-5. Review.

20.

Pharmacotherapy of generalized anxiety disorder.

Rickels K, Rynn M.

J Clin Psychiatry. 2002;63 Suppl 14:9-16. Review.

Items per page

Supplemental Content

Write to the Help Desk